- Rockley Photonics Holdings Ltd RKLY expanded the range of possible applications for its non-invasive biomarker sensing technology into new segments of the medical technology field.
- Rockley collaborated with two leading medical equipment and device manufacturers, who have a combined history of over 200 years and represent over $40 billion of revenue in the medical equipment market.
- Cowen analyst Paul Silverstein initiated coverage of the silicon photonics technology company with an Outperform rating and $22 price target, implying an upside of 134.5%.
- Price Action: RKLY shares traded higher by 6.99% at $10.05 in the market session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorLong IdeasNewsPrice TargetInitiationSmall CapAnalyst RatingsMoversTechTrading IdeasBriefswhy it's moving
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
